NCT02677324 Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia Status COMPLETED Phase PHASE2
NCT02675959 Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease Status RECRUITING Phase PHASE2
NCT02670525 Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome Status ACTIVE_NOT_RECRUITING Phase NA
NCT02666378 Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer Status COMPLETED Phase N/A
NCT02666209 Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma Status NO_LONGER_AVAILABLE Phase N/A
NCT02665195 Prospective Registry of Multiplex Testing (PROMPT) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02661815 A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer Status TERMINATED Phase PHASE1
NCT02658279 Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype Status ACTIVE_NOT_RECRUITING Phase NA
NCT02657551 A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02657343 An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. Status COMPLETED Phase PHASE1/PHASE2
NCT02653755 The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02648997 An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02644382 Improving Surgical Decision-making in Young Women With Breast Cancer Status COMPLETED Phase N/A
NCT02623972 A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02604511 Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing Status COMPLETED Phase PHASE2
NCT02592330 Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft Status COMPLETED Phase PHASE1/PHASE2